Topics

STAT Plus: A second generic drug maker admits to price fixing as part of a far-reaching probe into generics

11:33 EST 4 Dec 2019 | STAT

Rising Pharmaceuticals agreed to pay more than $3 million to resolve criminal and civil charges related to a price-fixing scheme involving a high blood pressure pill.

Original Article: STAT Plus: A second generic drug maker admits to price fixing as part of a far-reaching probe into generics

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: A second generic drug maker admits to price fixing as part of a far-reaching probe into generics"

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...